Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely

• Main Authors: Ohyashiki JH (Author), Ohtsuki K (Author), Mizoguchi I (Author), Yoshimoto T (Author), Katagiri S (Author), Umezu T (Author), Ohyashiki K (Author)
• Formato: Livro
• Publicado em: Dove Medical Press, 2014-08-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Junko H Ohyashiki,1 Kazushige Ohtsuki,1 Izuru Mizoguchi,2 Takayuki Yoshimoto,2 Seiichiro Katagiri,3 Tomohiro Umezu,1,4 Kazuma Ohyashiki3,4 1Department of Molecular Oncology, Institute of Medical Science, 2Department of Immunoregulation, Institute of Medical Science, 3Department of Hematolog...